BlackRock, Inc. 13D and 13G filings for ORIC Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | BlackRock Inc. BLK | 5,473,145 5.600% | 1,852,921 (+51.18%) | Filing |
| 2025-07-17 7:54 pm Sale | 2025-06-30 | 13G | ORIC PHARMACEUTICALS INC ORIC | BlackRock Inc. BLK | 3,620,224 4.200% | -1,481,593 (-29.04%) | Filing |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | ORIC PHARMACEUTICALS INC ORIC | BlackRock Inc. BLK | 5,101,817 7.200% | 0 (Unchanged) | Filing |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | ORIC PHARMACEUTICALS INC ORIC | BlackRock Inc. BLK | 5,101,817 7.200% | 2,106,785 (+70.34%) | Filing |
| 2024-02-07 5:09 pm Sale | 2024-01-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | BlackRock Inc. BLK | 2,995,032 4.500% | -100,616 (-3.25%) | Filing |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | BlackRock Inc. BLK | 3,095,648 5.700% | 2,296,307 (+287.28%) | Filing |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | ORIC PHARMACEUTICALS INC ORIC | BlackRock Inc. BLK | 799,341 2.000% | -1,616,006 (-66.91%) | Filing |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | BlackRock Inc. BLK | 2,415,347 6.100% | 536,439 (+28.55%) | Filing |